Co-Diagnostics Inc CODX

NAS: CODX | ISIN: US1897631057 30/04/2025

0,351 USD (-2,01%)

(-2,01%) 30/04/2025

Grafiek Co-Diagnostics Inc

Grafiek Co-Diagnostics Inc

1 dag1d -2,01%
1 week1w -2,50%
1 maand1m 7,08%
3 maanden3m -52,24%
6 maanden6m -70,99%
1 jaar1j -70,50%
5 jaar5j -97,39%

Co-Diagnostics Inc in het nieuws

Toon enkel gratis nieuws

27 maart 2025 · Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results · Persbericht

13 maart 2025 · Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast · Persbericht

6 maart 2025 · Co-Diagnostics, Inc. Wins Dismissal of Class Action Lawsuit · Persbericht

3 maart 2025 · Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025 · Persbericht

5 september 2024 · Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test · Persbericht

15 augustus 2024 · Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C. · Persbericht

8 augustus 2024 · Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results · Persbericht

29 juli 2024 · Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago · Persbericht

25 juli 2024 · Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast · Persbericht

2 juli 2024 · Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States · Persbericht

Profiel Co-Diagnostics Inc

Gezondheidstechnologie

Productie van medische instrumenten

Website: codiagnostics.com

Hoofdzetel: Salt Lake City, Utah Verenigde Staten

CEO: Dwight Egan

Werknemers: 80

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe